Ad is loading...
VHYAX
Price
$39.39
Change
-$0.15 (-0.38%)
Updated
Nov 15 closing price
VIVIX
Price
$68.70
Change
-$0.26 (-0.38%)
Updated
Nov 15 closing price
Ad is loading...

VHYAX vs VIVIX

Header iconVHYAX vs VIVIX Comparison
Open Charts VHYAX vs VIVIXBanner chart's image
Vanguard High Dividend Yield Index Adm
Price$39.39
Change-$0.15 (-0.38%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index I
Price$68.70
Change-$0.26 (-0.38%)
VolumeN/A
CapitalizationN/A
VHYAX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VHYAX vs. VIVIX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VHYAX is a Buy and VIVIX is a StrongSell.

FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. VHYAX (72.6B). VHYAX pays higher dividends than VIVIX: VHYAX (2.80) vs VIVIX (2.37). VHYAX was incepted earlier than VIVIX: VHYAX (6 years) vs VIVIX (26 years). VIVIX is a more actively managed with annual turnover of: 10.00 vs. VHYAX (6.00). VHYAX has a lower initial minimum investment than VIVIX: VHYAX (3000) vs VIVIX (5000000). VHYAX (25.61) and VIVIX (25.54) have marching annual gain over last year. VIVIX return over 5 years is better than : 50.79 vs. VHYAX (43.74).
VHYAXVIVIXVHYAX / VIVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years26 years-
Gain YTD17.84617.922100%
Front LoadN/AN/A-
Min. Initial Investment300050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets72.6B184B39%
Annual Yield % from dividends2.802.37118%
Returns for 1 year25.6125.54100%
Returns for 3 years18.8721.5787%
Returns for 5 years43.7450.7986%
Returns for 10 yearsN/A110.50-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRMB70.62-0.12
-0.17%
Trimble
VSTM3.99-0.14
-3.39%
Verastem
AEI1.04-0.04
-3.70%
Alset
CCO1.57-0.07
-4.27%
Clear Channel Outdoor Holdings
PTCT39.23-3.15
-7.43%
PTC Therapeutics